Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Connect Biopharma Holdings Ltd
CNTBCurrent price
1.25 USD
-0.03 USD (-2.34%)
Last closed
1.35 USD
Company
www.connectbiopharm.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
69 980 808 USD
Yield for 12 month
+25.00 %
1Y
3Y
5Y
10Y
15Y
CNTB
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma, currently under Phase 3 studies; and icanbelimod (formerly CBP-307), an oral small molecule Sphingosine 1-Phosphate Receptor 1 modulator, currently under Phase 2 clinical for the treatment of ulcerative colitis and Crohn's disease. The company was founded in 2012 and is based in San Diego, California. Address: 12265 El Camino Real, San Diego, CA, United States, 92130
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures CNTB
1 year
3 years
5 years
10 years
EBITDA
-64 233 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-27.07 %
PEG Ratio
–
Return On Equity TTM
-46.03 %
Wall Street Target Price
7 USD
Revenue TTM
–
Book Value
1.83 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.08 USD
Diluted Eps TTM
-1.08 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CNTB
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CNTB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation CNTB
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
0.7791
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
0.1857
Price Book MRQ
0.6926
Financials CNTB
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CNTB
For 52 weeks
0.53 USD
2.84 USD
50 Day MA
1.54 USD
Shares Short Prior Month
27 784
200 Day MA
1.35 USD
Short Ratio
0.17
Shares Short
15 465
Short Percent
0.05 %
BeatStart